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•  This study provides a baseline of the provision of chronic disease management in Irish 
general practice in 2010. 
•  It compares Ireland to survey data of primary care physicians in 11 countries, allowing Irish 
general practice to be measured against international counterparts.
•  The study achieved a 72% response rate.
•  63% of GPs believe that there are some good things in our health service but significant 
changes are needed to facilitate the management of chronic care.
•  GPs reported wide use of information technology systems within the practices.
•  99% of respondents indicated that they provide an out-of-hours service for their patients, 
which places Ireland as the leader of provision of access for patients outside of surgery 
hours, compared to their international counterparts.
•  A small number of routine clinical audits are being performed.
•  Irish GPs use evidence based guidelines for the treatment of diabetes, asthma or COPD and 
hypertension, to the same frequency as their international counterparts. 
•  The main barriers to delivering chronic care are an increased workload and a lack of 
appropriate funding for chronic disease management. 
•  GPs are interested in targeted payments for the management of chronic disease.
•  36% of respondents indicated that their practice was functioning as a part of a primary care 
team. 
•  GPs’ perceptions indicate that they believe substantial differences remain between 
fee-paying patients and GMS entitled patients in terms of access to diagnostic tests, 
longer waiting times to see a hospital based specialist and longer waiting times to receive 
treatment after a diagnosis.
•  GPs perceive that their fee-paying patients experience difficulties in paying for medications 
and other out-of-pocket expenses.
•  GPs support the concept of shared care initiatives between themselves and local hospitals. 
Summary
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It is ten years since the Primary Care Strategy (2) was launched and progress has been slow and 
hesitant. Now many of the certainties and practices of previous decades are likely to be replaced, 
and the prospect of change is more likely especially in the area of chronic disease management.  
It is timely to look at how we deliver chronic disease care in General Practice, and also to consider 
what aspects of this we may care to change, to augment, to dispense with, or to maintain.
The Chronic Care Model (3) has broad international acceptance as a model to provide guidance 
on the shift from our current predominantly acute and episodic model of care to a lifelong 
model of promotion, prevention, early intervention and chronic care. The Chronic Care Model 
encompasses both non-communicable disease such as diabetes, heart disease, chronic obstructive 
pulmonary disease, cancers and depression and communicable diseases such as AIDS, and 
sometimes tobacco, alcohol and problem drug use are included. The core elements revolve around 
organizational changes in health care delivery – better connected teams with clinical informatics 
and decision support, proactive planned care around evidence, and patient and care giver specific 
needs with greater support for self-care. Many countries are engaged in the transition to a Chronic 
Care Model. These range from the West including the US, Europe, Canada, Australia, New Zealand, 
as well as Ireland to the developing world including China, India and South East Asia (4). However 
the transition in well established systems is difficult to make if initiatives are ‘top down’, particularly 
without patient centred approaches (5) and physician leadership or active involvement (6). 
Primary Care, and General Practice as a core provider of healthcare, are central to this transition 
(7) and provide cost effective alternatives to other models of care delivery. Making change 
and transforming Primary Care into effective working models is challenging, and needs to be 
undertaken with appropriate supporting research (8). The Chronic Care Model contains several key 
elements. Many elements of the model clearly exist in Irish General Practice, and it is important to 
build improvements on existing strengths. The roll out of Primary Care Teams in Ireland presents 
an opportunity to make this shift. It is important to have baseline data against which to measure 
the impact of the ongoing care transition.
Irish general practice places strong emphasis on person centred care (9) of the individual 
with complex multimorbidity (10), yet it is important to incorporate additional elements in the 
prevention and management of chronic disease (11). Less well developed areas, where more 
structured care is required to address the elements of the chronic care model include clinical 
information systems, decision support, use of evidence based guidelines and self-management 
support (12,13). International literature on successful chronic disease care points to key 
infrastructural elements in general practice, including disease registers, information systems, use 
of guidelines, and greater interaction between secondary and primary care (9). These elements 
have been associated with improvement in quality of care (14) and have been widely implemented 
in some countries including the UK. However, there are concerns that the emphasis on the 
technical aspects of care compromises the traditional doctor-patient relationship and is the focus 
of intense debate (15). 
Introduction
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Rationale
Within the Irish healthcare system, there is considerable momentum in relocating the care of 
individuals with chronic disease from the hospital environment to primary care. Nationally 
stated policy (16), together with varied levels of support within the medical and allied 
professions, favours a shift of such care out of the tertiary and secondary care environment, 
and more completely into the primary care environment (2) General Practice is understood to 
have a central role in this policy.
Within General Practice, it is assumed that individual GPs vary in their beliefs regarding the 
capacity of General Practice to manage this development in a manner, which is consistent 
with delivering an appropriate level of care. While GPs have been involved in population-
based initiatives, uncertainties exist in relation to the capacity, organisation and ability of 
General Practice to address the anticipated demand in the transfer of such care from the 
hospital to the community.
Examples of programmes where GP involvement in Ireland has been directly and significantly 
engaged in such initiatives include Heartwatch (17), The North Dublin Diabetes Shared Care 
project (18) and more recently, The National Cervical Screening Programme (19).
This report examines elements of current Irish general practice, which are relevant to its 
degree of readiness to engage with chronic disease management, in keeping with current best 
practice internationally. 
Given the importance of the interaction between primary and secondary care (20), the 
study includes data on the experiences of those GPs included in the study in relation to the 
interface between general practice and hospital services as GPs perceive it. 
It includes data on the experiences of individual GPs as they relate to features of the mixed 
public private healthcare system, which presently remains a characteristic feature of the Irish 
healthcare system, and which requires to be properly considered, in the planned transfer of 
chronic disease management into general practice.
The data collected in this report are presented in a complete and direct manner. It will serve 
as a baseline on relevant organisational aspects of general practice in Ireland for 2010, 
against which future change can be measured. 
Finally, given that the survey instrument is closely based on an internationally validated 
questionnaire, with recent comparative data available from 11 countries (1), this report places 
Irish general practice in an international context, in the area of Chronic Disease Management 
(CDM).
Section One:  
Rationale, Aims and Objectives 
Section O
ne: Rationale, Aim
s and O
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Aim of Research 
The aim of this research is to survey Irish general practitioners to identify what elements of 
the Chronic Care Model are currently in place. This will provide a baseline measure of Chronic 
Disease Management (CDM) for benchmarking against ongoing transformation in the future. 
Objectives 
1.  To conduct a survey to deliver a baseline measure of CDM. 
2.  To identify strengths and weaknesses of CDM in Irish general practice. 
3.  To inform the wider profession and policy makers. 
4.  To examine which elements of the Chronic Care Model are in place.
5.  To compare CDM in Ireland with international data. 
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Design
This study utilised a cross-sectional design whereby a survey questionnaire was posted to a 
random selection of GPs nationally. 
Sampling 
We compiled a comprehensive national database of general practitioners in Ireland. This 
task was achieved through cross-referencing the General Medical Scheme, Mother and Infant 
scheme, cervical screening and Medical directory databases. The database was then checked 
to remove doctors whom we knew to be no longer in practice. This resulted in a database with 
2,636 doctors actively in general practice. A 20% random sample was generated from this 
database using a random numbers generator. This resulted in a total of 527 doctors from a 
possible 2,636 selected to participate in the study. 
Survey instrument
The questionnaire was developed, by combining relevant questions from two international 
questionnaires on chronic disease management. First, the Use of Chronic Care Model 
Elements Survey (3) and secondly, questions from A Survey Of Primary Care Physicians In 
Eleven Countries (1). This resulted in a thirty-one item questionnaire which covered topics 
such as respondents’ perception of CDM, access to care for patients, evidence of managed 
care within the practices, resources available to the GP, the use of information technology 
within the practices, respondents’ perceptions of the barriers to effective CDM, future 
development of CDM and demographic details (see Appendix). The questionnaire was 
piloted for comprehension and ease of completion before dissemination as the final study 
instrument. 
Procedure
The postal questionnaire was conducted in three separate waves at one-month intervals, to 
secure a good response rate. The sample was circulated in March, April and May 2010 with a 
questionnaire accompanied by a stamped addressed envelope for ease of return and a cover 
letter outlining the purpose of the study and assuring respondents of total confidentiality 
within the research team. A unique identifying number (UIN) ensured the anonymity of the 
respondent. Respondents who had completed and returned the questionnaire in a previous 
wave were checked off the database using their UIN to ensure that they did not receive 
another questionnaire in a subsequent wave. 
Section Tw
o: M
ethod
Section Two: Method
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Response rate
The first postal questionnaire wave was sent in March 2010 to all GPs who were randomly 
selected to receive a questionnaire (N=527). 
A total of 240 completed questionnaires were returned within Wave 1 (46% response 
rate – Wave 1). The non-responders were sent a follow-up reminder letter and the survey 
questionnaire again in April 2010 (Wave 2). A total of 92 completed questionnaires were 
returned within Wave 2 (17% response rate - Wave 2). In May 2010 a third and final reminder 
letter plus an additional questionnaire was sent to all non-responders. This resulted in an 
additional 48 completed questionnaires being returned (9% response rate – Wave 3). This 
cumulated to a total of 380 completed questionnaires returned to us throughout the three 
postal waves, resulting in an overall response rate of 72%.
Respondent profile
This section outlines the age and sex of respondents as well as the location and size of their 
practices, the profile of the patients attending the practices and whether the practice is 
involved in medical education/training. 
Practice location
A total of 97 (25%) respondents indicated that their practice is based within a city. 82 (22%) 
indicated that their practice was located within a suburb. 129 (34%) indicated that their 
practice was located within a small town. 71 (19%) indicated that their practice was located 
within a rural setting. 
Age of respondents 
Thirty (8%) respondents indicated that their age was under 35 years. 157 (42%) indicated that 
their age was between 35-49 years. 166 (44%) indicated that their age was between 50-64 
years. 24 (6%) indicated that their age was 65 years or older. 
Gender of respondents 
A total of 239 (63%) respondents were male, 139 (37%) of respondents were female, which is 
in line with national proportions (21). 
Section Three: Results
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Section Three: Results
Practice description 
A total of 158 (42%) respondents indicated that they are working within a practice that has 
three or more doctors. 108 (28%) of respondents indicated that they are working within 
practices with two doctors. 113 (30%) of respondents indicated that they are working in 
single-handed practices. 
Profile of patients attending respondents’ practices 
Table 1: Profile of patients attending the practices 
Practice type Percentage
GMS and Private (N=357; 93%) 96%
Private only (N=358; 94%) 2.5%
‘Doctor Only’ card holders (N=358; 94%) 1%
Percentage of ‘other’ patients (N=358; 94%) 0.5%
Involvement in Medical Education/Training 
A total of 198 (52%) respondents indicated that their practice was involved in medical 
education or training. Of the 198 respondents who reported that they were involved in 
medical education, 156 (79%) reported that this was at undergraduate level and 120 (61%) 
indicated that this involvement was at postgraduate level. A total of 79 (40%) respondents 
indicated that their practices are involved in both undergraduate and postgraduate medical 
education or training. 
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Perception of chronic disease management
This section examines GPs’ perception of chronic disease management within the Irish health 
care system. 
Which of the following statements come closest to expressing your overall 
view of chronic disease management (CDM) in our health care system?
Figure 1: GPs perception of Chronic Disease Management in the Irish health care 
system (N=368)
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Twenty-one (5.5%) respondents indicated that on the whole, the health care system works 
pretty well, and only minor changes are necessary to make CDM work better. 240 (63%) 
respondents indicated that there are some good things in our health system, but significant 
changes are needed to make CDM work better. 107 (28.2%) respondents indicated that our 
health care system has so much wrong with it that we need to completely rebuild it for CDM. 
Male GPs were more likely than female GPs to think that significant changes are needed in 
the health care system to make CDM work better. GPs working in larger practices were also 
more likely to think that significant changes are needed. The age of the respondents made no 
difference. 
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Section Three: Results
Table 2: GPs’ perception of chronic disease management in their indigenous 
healthcare systems (%). Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
On the whole the 
health care system 
works pretty well and 
only minor changes are 
necessary to make it 
work better
There are some 
good things in our 
health system, but 
fundamental changes 
are needed to make it 
work better
Our health care  
system has so much 
wrong with it that we 
need to completely 
rebuild it
Ireland 5.5 63 28.2
Australia 23 71 6
Canada 33 62 4
France 41 53 6
Germany 18 51 31
Italy 38 58 4
Netherlands 60 37 1
New Zealand 42 57 1
Norway 56 40 2
Sweden 37 54 7
UK 47 50 3
US 17 67 15
Footnote: Ireland (N=380); Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); 
Italy (N=844); Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK 
(N=1062); US (N=1442)
Irish GPs display much more discontent with the health care system than most other countries 
with only 5.5% thinking it works well. The remainder thinks it needs fundamental change.
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Access
This section outlines GPs’ perception of the ease of access that their patients experience 
when attempting to access health care services and types of health care providers and ease 
of paying for medical costs. It also reports on the types of out-of-hours services respondents 
provide for their patients. 
How often do your fee-paying patients experience the following? 
Table 3: GPs’ perception of how often fee-paying patients experience difficulties in 
accessing services and paying for medical costs. 
Often Sometimes Rarely Never
Experience long waiting times to see a 
hospital-based specialist (N=376; 99%)
132 (35%) 129 (34%) 98 (26%) 17 (5%)
Have difficulty getting specialised 
diagnostic tests (e.g., CT imaging) 
(N=376; 99%)
120 (32%) 135 (36%) 106 (28%) 15 (4%)
Experience long waiting times to receive 
treatment after diagnosis (N=376; 99%)
76 (20%) 148 (39%) 133 (35%) 19 (6%)
Have difficulty paying for medications 
or other out-of-pocket costs (N=373; 
98%)
151 (40%) 178 (47%) 43 (11%) 1 (0.3%)
The majority of GPs feel that their fee-paying patients experience difficulties in paying for 
medications or other out-of-pocket expenses. Two thirds of GPs believe that their fee-paying 
patients have difficulty getting specialised diagnostic tests, experience long waiting times to 
see a hospital based specialist and to receive treatment after a diagnosis. 
Age, gender or size of the practice did not have an effect on GPs’ perceptions of their 
fee-paying patients experiences in accessing services or paying for medical costs. 
How often do your GMS entitled patients experience the following? 
Table 4: GPs’ perception of how often GMS entitled patients experience difficulties 
in accessing services and paying for medical costs. 
Often Sometimes Rarely Never
Experience long waiting times to see a 
hospital-based specialist (N=369; 97%)
342 (93%) 25 (7%) 1 (0.3%) 1 (0.3%)
Have difficulty getting specialised 
diagnostic tests (e.g., CT imaging) 
(N=369; 97%)
326 (88%) 34 (9%) 6 (2%) 3 (1%)
Experience long waiting times to receive 
treatment after diagnosis (N=368; 96%)
253 (69%) 93 (25%) 20 (5%) 2 (0.5%)
Have difficulty paying for medications or 
other out-of-pocket costs (N=368; 96%)
87 (24%) 92 (25%) 123 (33%) 66 (18%)
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Section Three: Results
Over half of GPs believe their General Medical Scheme (GMS: a medical card issued by the 
Health Services Executive in Ireland which allows the holder to receive certain health services 
free of charge) entitled patients rarely or never have difficulty paying for medications or 
other out-of-pocket costs. The majority of GPs believe that their GMS entitled patients have 
difficulty getting specialised diagnostic tests, experience long waiting times to see a hospital 
based specialist and to receive treatment after diagnosis. 
Age, gender or size of the practice did not have an effect on GPs’ perceptions of their GMS 
entitled patients experiences in accessing services or paying for medical costs. 
Table 5: GPs’ perception of the long waiting times their patients’ experience, when 
trying to see a specialist. Comparison between Ireland and data collected by the 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Often Sometimes Rarely Never
Experience long waiting times to see a specialist 
Ireland (N=358; fee paying patients) 35% 34% 26% 5%
Ireland (N=357; GMS entitled patients) 93% 7% 0.3% 0.3%
Australia (N=1016) 34% 55% 10% *
Canada (N=1401) 75% 23% 2% *
France (N=502) 53% 31% 13% 2%
Germany (N=715) 66% 24% 8% 1%
Italy (N=844) 75% 20% 5% *
Netherlands (N=614) 36% 55% 9% *
New Zealand (N=500) 45% 49% 6% *
Norway (N=744) 55% 38% 6% 1%
Sweden (N=1450) 63% 31% 5% *
UK (N=1062) 22% 57% 19% 2%
US (N=1442) 28% 47% 22% 2%
The majority of the respondents (93%) believe that their GMS entitled patients often 
experience long waiting times, compared to 35% perceiving that their fee-paying patients 
often experience long waiting times. The percentage perceiving that their GMS entitled 
patients often have long waiting times is higher than in any of the other 11 countries surveyed 
by the Commonwealth Fund.
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Table 6: GPs perceptions of the difficulty that their patients have in getting 
specialised diagnostic tests. Comparison between Ireland and the Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Often Sometimes Rarely Never
Have difficulty getting specialised diagnostic tests 
Ireland (N=358; fee paying patients) 32% 36% 28% 4%
Ireland (N=357; GMS entitled patients) 88% 9% 2% 1%
Australia (N=1016) 21% 56% 20% 2%
Canada (N=1401) 47% 38% 13% 2%
France (N=502) 42% 32% 18% 7%
Germany (N=715) 26% 35% 28% 10%
Italy (N=844) 52% 33% 12% 2%
Netherlands (N=614) 15% 51% 30% 4%
New Zealand (N=500) 60% 32% 8% *
Norway (N=744) 5% 50% 43% 2%
Sweden (N=1450) 6% 48% 42% 4%
UK (N=1062) 14% 48% 30% 8%
US (N=1442) 58% 38% 3% 1%
More Irish GPs (88%) believe that their GMS entitled patients experience difficulty in getting 
specialised diagnostic tests compared to the perceptions of their international counterparts, 
of difficulty for their patients. The Irish GPs’ perception of the difficulty in getting specialised 
tests for their fee-paying patients, was about average for their international counterparts.
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Section Three: Results
Table 7: GPs’ perceptions of the long waiting times their patients experience when 
waiting to receive treatment after a diagnosis. Comparison between Ireland and data 
collected by Commonwealth Fund (2009) International Survey of Primary  
Care Doctors (1)
Often Sometimes Rarely Never
Experience long waiting times to receive treatment after diagnosis
Ireland (N=358; fee paying patients) 20% 39% 35% 6%
Ireland (N=357; GMS entitled patients) 69% 25% 5% 0.5%
Australia (N=1016) 21% 60% 19% 1%
Canada (N=1401) 29% 48% 21% 1%
France (N=502) 19% 38% 33% 10%
Germany (N=715) 18% 45% 31% 5%
Italy (N=844) 40% 43% 15% 2%
Netherlands (N=614) 31% 57% 12% *
New Zealand (N=500) 44% 46% 9% 1%
Norway (N=744) 23% 56% 20% 1%
Sweden (N=1450) 30% 48% 20% 2%
UK (N=1062) 17% 50% 29% 3%
US (N=1442) 8% 35% 48% 10%
69% of the Irish GPs perceive that their GMS entitled patients often experience long 
waiting times to receive treatment after diagnosis, higher than the rate for any of the other 
11 countries; whereas only 20% of Irish GPs perceive that their fee paying patients often 
experience long waiting times, similar to the perceptions of their international colleagues.
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Table 8: GPs’ perception of the difficulty their patients have in paying for 
medications. Comparison between Ireland and data collected by Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Often Sometimes Rarely Never
Have difficulty paying for medications or other out-of-pocket costs
Ireland (N=358; fee paying patients) 40% 47% 11% 0.3%
Ireland (N=357; GMS entitled patients) 24% 25% 33% 18%
Australia (N=1016) 23% 63% 13% 1%
Canada (N=1401) 27% 56% 15% 1%
France (N=502) 17% 50% 26% 7%
Germany (N=715) 28% 48% 21% 2%
Italy (N=844) 37% 49% 13% 1%
Netherlands (N=614) 33% 50% 17% 1%
New Zealand (N=500) 25% 62% 13% *
Norway (N=744) 5% 50% 43% 2%
Sweden (N=1450) 6% 48% 42% 4%
UK (N=1062) 14% 48% 30% 8%
US (N=1442) 58% 38% 3% 1%
Almost a quarter of Irish GP respondents believe that GMS entitled patients often have 
difficulty in paying for medications or other out of pocket expenses. This figure is about 
average cross the 11 countries in the Commonwealth Fund study.
However, 40% of the Irish GPs perceive that their fee-paying patients often experience this 
problem, with only the US GPs perceiving a higher incidence of the problem.
It is interesting that in most countries, even those with universal access, patients have 
difficulties paying for services, experience delays in seeing specialists and in receiving 
appropriate treatments.
What out of hours service does your practice utilise? 
A total of 375 (99%) respondents indicated that they have an out-of-hours service for their 
patients. 62 (16%) respondents indicated that they have a local rota. 29 (76%) respondents 
indicated that they have a co-op service in place. 75 (20%) respondents indicated that 
they have a deputising service in place as their out-of-hours service for patients. 49 (13%) 
respondents had two or more out-of-hours services available for their patients. 
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Section Three: Results
Figure 2: Which type of out-of-hours service do GPs utilise?
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Table 9: Does your practice have an arrangement where patients can see a doctor or 
nurse if needed when the practice is closed (after-hours) without going to the hospital 
accident and emergency department? Comparison between Ireland and data collected 
by Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
YES Percent
Ireland 99
Australia 50
Canada 43
France 78
Germany 54
Italy 77
Netherlands 97
New Zealand 89
Norway 38
Sweden 54
UK 89
US 29
Footnote: Ireland (N=380); Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); 
Italy (N=844); Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK 
(N=1062); US (N=1442)
Ireland does well on this metric, which is a combination of out-of-hours co-ops, deputising 
and rotas.
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Outside of your practice, do your patients have effective local access to the 
following? 
Table 10: GPs’ perception of effective local access to services for both private fee 
paying and GMS entitled patients. 
Yes  
(Private fee paying patients)
Yes  
(GMS entitled patients)
Physiotherapist 350 (93%) 238 (63%)
Chiropodist 284 (75%) 178 (47%)
Dietician 245 (65%) 189 (5%)
Psychologist 219 (58%) 92 (24%)
Speech and language therapist 151 (40%) 141 (37%)
Social worker 143 (38%) 197 (52%)
Occupational therapist 139 (37%) 156 (41%)
A total of 378 (99.4%) respondents answered this question. Missing data = 2 (0.6%). 
Overall GPs reported that the majority of their private fee paying patients have effective access 
to a physiotherapist, a chiropodist, a psychologist and a dietician, whereas the majority of 
their GMS entitled patients only have effective access to a physiotherapist, with relatively poor 
levels of access to other disciplines. Neither the age nor gender of the GP, nor the size of the 
practice within which they worked, had any impact on effective access to local services. 
Evidence of managed care 
This section examines the use of evidence-based treatment guidelines and strategies for 
managing chronic conditions such as diabetes. It also describes the frequency of routine 
clinical audit completions within the practices. 
Does your practice routinely use written evidence-based treatment 
guidelines to treat the following conditions? 
Table 11: Number of practices that routinely use, written evidence-based treatment 
guidelines, for chronic disease conditions. 
Yes, routinely  
use guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Hypertension (N=375; 98%) 297 (79%) 73 (20%) 5 (1.3%)
Asthma or COPD (N=375; 98%) 279 (74%) 89 (24%) 7 (2%)
Diabetes (N=375; 98%) 267 (71%) 103 (28%) 5 (1.3%)
Depression (N=375; 98%) 126 (34%) 227 (61%) 22 (6%)
ADHD (N=367; 96%) 54 (15%) 213 (58%) 100 (27%)
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The majority of GPs reported that they are using evidence-based guidelines for diabetes, 
asthma or COPD and hypertension, and not using guidelines routinely for depression and 
ADHD. 
The age of the GP had a role to play in whether guidelines were being routinely used. 
Older GPs (50+) were less likely to use guidelines for the treatment of asthma or COPD and 
hypertension. Neither the size of the practice nor the gender of the GP had any bearing on 
whether guidelines were utilised for management of the above five chronic conditions. 
Table 12: Does your practice routinely use, written evidence-based guidelines 
to treat hypertension? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Yes, routinely use 
guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Ireland (N=375) 79% 20% 1.3%
Australia (N=1016) 82% 16% 1%
Canada (N=1401) 76% 16% 1%
France (N=502) 50% 37% 12%
Germany (N=715) 70% 21% 2%
Italy (N=844) 94% 5% 1%
Netherlands (N=614) 90% 8% *
New Zealand (N=500) 75% 24% 1%
Norway (N=744) 81% 17% 1%
Sweden (N=1450) 91% 7% 2%
UK (N=1062) 96% 3% 1%
US (N=1442) 69% 16% 2%
It appears that Irish GPs use written, evidence-based guidelines to treat hypertension to the 
same extent as their international counterparts.
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Table 13: Does your practice routinely use, written evidence-based guidelines 
to treat asthma or COPD? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Yes, routinely use 
guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Ireland (N=375) 74% 24% 2%
Australia (N=1016) 85% 13% 1%
Canada (N=1401) 72% 20% 1%
France (N=502) 44% 38% 14%
Germany (N=715) 73% 24% 1%
Italy (N=844) 89% 9% 1%
Netherlands (N=614) 87% 12% 1%
New Zealand (N=500) 87% 13% *
Norway (N=744) 81% 18% *
Sweden (N=1450) 84% 12% 3%
UK (N=1062) 96% 3% 1%
US (N=1442) 76% 19% 2%
Irish GPs report routinely using written, evidence-based guidelines, to treat asthma or COPD, 
to the same extent as their international counterparts.
Table 14: Does your practice routinely use, written evidence-based guidelines to 
treat diabetes? Comparison between Ireland and data collected by Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Yes, routinely use 
guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Ireland (N=375) 71% 28% 1.3%
Australia (N=1016) 87% 12% 1%
Canada (N=1401) 78% 14% 1%
France (N=502) 60% 28% 9%
Germany (N=715) 73% 20% 1%
Italy (N=844) 93% 5% 1%
Netherlands (N=614) 97% 2% *
New Zealand (N=500) 93% 6% *
Norway (N=744) 86% 14% *
Sweden (N=1450) 93% 5% 1%
UK (N=1062) 96% 3% *
US (N=1442) 74% 12% 2%
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Irish GPs report routinely using written, evidence-based guidelines to treat diabetes, to a 
similar extent as their counterparts in Germany, the US and Canada; but to a lesser extent 
than those in the other countries surveyed.
Table 15: Does your practice routinely use, written evidence-based guidelines to 
treat depression? Comparison between Ireland and data collected by Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Yes, routinely use 
guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Ireland (N=375) 34% 61% 6%
Australia (N=1016) 70% 26% 2%
Canada (N=1401) 43% 43% 8%
France (N=502) 29% 49% 19%
Germany (N=715) 23% 50% 15%
Italy (N=844) 38% 45% 13%
Netherlands (N=614) 31% 60% 9%
New Zealand (N=500) 65% 34% 1%
Norway (N=744) 49% 47% 4%
Sweden (N=1450) 63% 30% 7%
UK (N=1062) 79% 17% 3%
US (N=1442) 42% 35% 8%
Irish GPs report routinely using written, evidence-based guidelines to treat depression, to a 
similar extent as their counterparts in France, Italy and the Netherlands, but to a lesser extent 
with regard to the other countries.
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Table 16: Does your practice routinely use, written evidence-based guidelines to 
treat ADHD? Comparison between Ireland and data collected by Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Yes, routinely use 
guidelines
No, do not routinely 
use guidelines
No guidelines 
available
Ireland (N=367) 15% 58% 27%
Australia (N=1016) 36% 29% 13%
Canada (N=1401) 26% 40% 14%
France (N=502) 13% 35% 34%
Germany (N=715) 13% 22% 18%
Italy (N=844) 13% 38% 13%
Netherlands (N=614) 6% 44% 40%
New Zealand (N=500) 42% 36% 10%
Norway (N=744) 56% 27% 5%
Sweden (N=1450) 6% 13% 21%
UK (N=1062) 34% 18% 11%
US (N=1442) 37% 28% 8%
Irish GPs report routinely use written, evidence-based guidelines to treat ADHD, to a greater 
extent than counterparts in France, Germany, Italy the Netherlands and Sweden, but to a 
lesser extent than their counterparts in the other countries surveyed. 
On the whole, guidelines are widely used in Ireland, except in the management of depression 
and ADHD, where they lag behind some of the other clinical areas. Guidelines in depression 
and to a lesser extent ADHD are more often dominated by pharmaceutical rather than 
professionally led advice and GPs are perhaps resistant to the source of such advice. It is an 
area for further dialogue between psychiatrists and GPs.
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Section Three: Results
Do you provide your patients who take multiple medications (e.g. 5 or more) 
with a written list of their medications? 
Figure 3: Provision of a written list of medications for patients taking multiple 
medications (N=378)
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Eighty-five (23%) respondents indicated that they routinely provide patients who take 
multiple medications, with a written list of all their medications, in addition to their 
prescriptions. 187 (49%) respondents indicated that they occasionally provide patients who 
take multiple medications with a written list of their medications. 106 (28%) respondents 
indicated that they do not provide patients who take multiple medications with a written list 
of their medications.
Neither the age, gender of the GP, nor the size of the practice nor whether the practice used 
electronic patients medical records had any impact on the frequency of the provision of a 
written list of multiple medications. 
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Table 17: Do you provide your patients who take multiple medications (e.g. 5 or 
more) with a written list of their medications? Comparison between Ireland and 
data collected by Commonwealth Fund (2009) International Survey of Primary Care 
Doctors (1)
Yes, routinely Yes, occasionally No
Ireland (N=378) 23% 49% 28%
Australia 12% 68% 20%
Canada 16% 36% 47%
France 43% 20% 37%
Germany 66% 31% 3%
Italy 59% 38% 2%
Netherlands 4% 65% 32%
New Zealand 5% 70% 25%
Norway 20% 69% 11%
Sweden 29% 61% 9%
UK 83% 10% 6%
US 30% 43% 26%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Almost a quarter of Irish GPs, report routinely providing their patients on multiple 
medications, with a written list of the medications. There is wide variation in this metric, from 
the Netherlands (4%) to the UK (83%). At 23%, Irish GPs are about mid-way on this table.
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Do you give your patients with chronic diseases written instructions about 
how to manage their own care at home? 
Figure 4: Provision of written instructions to patients with a chronic disease about 
how to manage their own care at home (N=379)
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Thirty (8%) respondents indicated that they routinely provide their patients with chronic 
diseases written instructions about how to manage their own care at home. 186 (49%) 
respondents indicated that they occasionally provide their patients with chronic diseases 
written instructions about how to manage their own care at home. 163 (43%) respondents 
indicated that they do not provide their patients with chronic diseases written instructions 
about how to manage their own care at home. 
Neither the age, gender of the GP nor the size of the practice nor whether the practice had 
electronic patient medical records had any impact on the frequency of provision of written 
instructions about home care for patients with a chronic disease. 
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Table 18: Do you give your patients with chronic diseases written instructions 
about how to manage their own care at home? Comparison between Ireland and 
data collected by Commonwealth Fund (2009) International Survey of Primary Care 
Doctors (1)
Yes, routinely Yes, occasionally No
Ireland (N=379) 8% 49% 43%
Australia 24% 69% 7%
Canada 16% 51% 32%
France 9% 57% 34%
Germany 23% 64% 12%
Italy 63% 35% 2%
Netherlands 22% 57% 21%
New Zealand 15% 76% 9%
Norway 9% 72% 20%
Sweden 11% 51% 38%
UK 33% 52% 14%
US 30% 50% 18%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Irish GPs provide their patients with chronic diseases, with written instructions on managing 
their condition at home, to a lesser extent than most of their international counterparts, 
although to the same extent as in France and Norway.
There is some variation in the use of written advice on medications internationally which 
is hardly surprising, as it is an undertaking that requires the supply of complex technical 
information for each patient who may be on multiple medications with a variety of possible 
interactions.
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Have you completed a full Audit Cycle within the last 5 years on 1 or more 
chronic diseases? 
Figure 5: Numbers of GPs who had completed a full Audit cycle within the last five 
years on one or more chronic diseases (N=376)
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A total of 95 (25%) respondents indicated that they had completed a full Audit Cycle within 
the last 5 years on 1 or more chronic diseases. 281 (75%) respondents indicated that they had 
not completed a full Audit Cycle within the last 5 years on 1 or more chronic diseases.
The GPs who had completed an Audit Cycle in the last five years were more likely to have 
electronic patient medical records, have a practice nurse available to them, be younger (<49 
years of age), be working within a three or more doctor practice and be involved in medical 
training. Also of those GPs who have completed an Audit Cycle in the last five years the 
majority were more likely to routinely use evidence-based guidelines for diabetes care. The 
gender of the GP had no impact on whether an Audit Cycle had been completed. 
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Table 19: Are any areas of clinical performance reviewed against targets at least 
annually? Comparison between Ireland and data collected by Commonwealth Fund 
(2009) International Survey of Primary Care Doctors (1)
YES 
Ireland (N=380) 25%
Australia 52%
Canada 32%
France 30%
Germany 55%
Italy 29%
Netherlands 41%
New Zealand 81%
Norway 18%
Sweden 46%
UK 92%
US 61%
 Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Audit of performance is low in Ireland but is poised to change with the new Medical Council 
requirement to carry out clinical audit from May 2011.
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How often do you currently use the following approaches to improving 
patient care for patients with diabetes? 
Table 20: Use of approaches to improve care for diabetic patients. 
Never Rarely Occasionally Usually Always
Use a register to identify and/
or track care of your patients 
(N=375; 99%)
120 (32%) 60 (16%) 84 (22%) 57 (15%) 54 (15%)
Use a tracking system to 
remind patients about needed 
visits (N=376; 99%)
166 (44%) 83 (22%) 55 (15%) 43 (11%) 29 (8%)
Follow up patients between 
visit by telephone (you or 
staff)
79 (21%) 57 (15%) 126 (33%) 89 (24%) 25 (7%)
Use published practice 
guidelines as the basis for 
your management (N=375; 
99%)
51 (14%) 42 (11%) 81 (22%) 136 (36%) 65 (17%)
Involve office staff in 
reminding patients in need 
of follow-up or other services 
(N=376; 99%)
68 (18%) 45 (12%) 102 (27%) 128 (34%) 33 (9%)
Assist patients in setting and 
attaining self-management 
goals (N=378; 99%)
28 (7%) 29 (8%) 90 (24%) 178 (47%) 53 (14%)
Refer patients to someone 
within your practice for 
education about their diabetes 
(N=373; 98%)
87 (23%) 46 (12%) 51 (14%) 119 (32%) 70 (19%)
Refer patients to someone 
outside your practice for 
education about their diabetes 
(N=374; 98%)
34 (9%) 53 (14%) 98 (26%) 133 (36%) 56 (15%)
Use flow charts to track 
critical elements of care 
(N=373; 98%)
169 (45%) 83 (22%) 61 (17%) 33 (9%) 27 (7%)
The majority of GPs usually or always use published practice guidelines as the basis for the 
management of diabetes; assist patients in setting and attaining self-management goals; 
refer diabetic patients to someone either within or outside the practice for education about 
their diabetes. Approximately one third of GPs usually or always use a diabetic register; follow 
up patients between visits by telephone and involve office staff in reminding diabetic patients 
about follow-ups or other services available to them. Less than one fifth of GPs usually or 
routinely use a tracking system to remind diabetic patients about visits or use flow charts to 
track critical elements of care. 
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Those GPs who have a practice nurse in their practice are more likely to follow up their 
diabetic patients between visits by telephone, more likely to assist patients in setting and 
attaining self-management goals, and are more likely to refer their diabetic patients to 
someone within their practice for education about their diabetes. Those GPs who have a 
receptionist are more likely to involve office staff in reminding patients in need of follow-up 
or other services. GPs with an electronic record system were more likely to use a register to 
identify and track the care of diabetic patients. However having a computer based records 
system had little influence on whether a GP used a tracking system to remind patients about 
needed visits or whether a flow chart was used to track critical elements of care. Having 
completed a full clinical audit cycle had little bearing on whether a GP use published practice 
guidelines as the basis of diabetic management. Being part of a functioning PCT had little 
influence on whether GPs referred their patients with diabetes to someone outside their 
practice for diabetes education. 
Use of disease registers is a key aspect of good chronic disease management, and 
documenting this metric, as a baseline in 2010, is an important benchmark against which to 
measure future progress, in an important and fundamental marker of good care.
Resources
This section examines what other types of healthcare providers and administrative staff each 
participating practice has available and the resources for the provision of CDM within the 
practice itself. It describes whether respondents believe that they are functioning as a part 
of a primary care team. It also outlines the severity of problems relating to shortages of GPs 
within practice areas and time spent on coordination of care.
In your own practice, other than doctors, does your practice include any other 
health care providers?
A total of 379 (99.7%) respondents answered this question. Missing data = 1 (0.3%) 
Table 21: The types of health care providers and administrative staff within the 
respondents’ practices. 
Yes
Receptionist 348 (92%)
Practice Nurse 306 (81%)
Administrator/Practice Manager 293 (78%)
Dietician 94 (25%)
Counsellor 70 (18%)
Psychologist 52 (14%)
Chiropodist 52 (14%)
Other 51 (13%)
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The majority of GPs have both administrative assistants and a practice nurse within their 
practices. These data also provide a key baseline against which future progress in expanding 
Practice Teams and Primary Care Team development can be measured.
Please rate the strength of your agreement with the following statements: 
Table 22: Strength of agreement on levels of resources for chronic disease 
management
Strongly 
disagree Disagree
Neither agree 
/disagree Agree
Strongly 
agree
I am happy with CDM 
as it is (N=370; 97%)
108 (29%) 158 (43%) 69 (19%) 22 (6%) 13 (3%)
I want to put more 
time and energy in 
the practice into CDM 
(N=372; 98%)
14 (4%) 35 (9%) 87 (23%) 173 (47%) 63 (17%)
PCT will enhance 
CDM in my practice 
(N=369; 97%)
31 (8%) 65 (18%) 110 (30%) 115 (31%) 48 (13%)
My local hospital 
should put more time 
and energy into CDM 
(N=372; 98%)
23 (6%) 56 (15%) 102 (28%) 139 (37%) 52 (14%)
I am willing to share 
the CDM workload 
with my local hospital 
(N=374; 98%)
11 (3%) 25 (7%) 50 (13%) 202 (54%) 86 (23%)
CDM should take 
place largely at a 
practice level and 
delivered largely by 
GPs (N=373; 98%)
18 (5%) 36 (10%) 76 (20%) 159 (42%) 84 (23%)
CDM should largely 
take place at practice 
level by nurses, 
under GP supervision 
(N=373; 98%)
19 (5%) 55 (15%) 103 (28%) 139 (37%) 57 (15%)
Seventy-two percent of GPs are not happy with CDM as it is currently delivered. Sixty-four 
percent of GPs either agree or strongly agree that they want to put more time and energy in 
their practice into CDM. GPs who work in large practices were more disposed to putting more 
time and energy into CDM. Neither age nor gender had any effect. Forty-four percent of GPs 
believe that PCT will enhance CDM in their practices, compared to twenty-six percent who 
do not hold this belief. Fifty-one percent of GPs believe that their local hospital should put 
more time and energy into CDM. Seventy-seven percent of GPs are willing to share the CDM 
workload with their local hospital.
There is support for CDM to be managed within the practices, with sixty-five percent of GPs 
thinking that CDM should take place largely at practice level and delivered largely by GPs. 
Fifty-two percent of GPs think that CDM should take place largely at practice level, delivered 
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by nurses, under GP supervision. Of those who responded positively to this question relating 
to nurse input into CDM, the majority (57%) actually had a nurse working in their practice. 
However, seventy-nine percent do not agree that CDM should take place largely at practice 
level by nurses working independently of GPs. Neither age, gender of the GP nor the size 
of the practice within which they worked had any effect on their opinion of nurses being 
involved in CDM.
This table indicates positivity towards more chronic disease management being undertaken 
by GPs and Practice Nurses, and in general practice. As such, it provides grounds for some 
optimism regarding the changes currently underway in transferring care from the hospital to 
the practice setting. 
Is your practice functioning as part of a primary care team? 
Figure 6: Numbers of GPs who indicated whether their practice is functioning as a 
part of a primary care team (N=372)
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A total of 135 (36%) respondents indicated that their practice was functioning as part of a 
primary care team. One-quarter of those GPs who responded that they are functioning as part 
of a PCT also have a practice nurse working with them. Neither age nor gender, nor practice 
size had any impact on GPs’ perceptions of functioning as a part of a PCT. 
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Table 23: Is your practice part of a network of other practices that share resources 
for managing patient care? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
YES 
Ireland (N=380) 36%
Australia 16%
Canada 37%
France 21%
Germany 24%
Italy 67%
Netherlands 48%
New Zealand 56%
Norway 25%
Sweden 61%
UK 38%
US 33%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
The proportion of Irish GPs who report being part of a network of practices that share 
resources for management of patient care, is on par with the proportions reported by most of 
the countries surveyed by the Commonwealth Fund.
Table 24: GPs’ perception on whether PCT will enhance their practice. 
Strongly 
disagree Disagree
Neither agree 
/disagree Agree
Strongly 
agree
PCT will enhance 
CDM in my practice 
N=369; 97%)
31 (8%) 65 (18%) 110 (30%) 115 (31%) 48 (13%)
Data in this table indicate that at present Irish GPs are largely positive in their disposition 
towards PCT development in 2010. Male GPs were more likely than female GPs to disagree 
that PCT would enhance their practice. Neither age of the GP nor practice size nor whether the 
GPs had previously indicated that they were currently functioning as a part of a PCT, had any 
impact. 
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How much of a problem, if any, are the following? 
Table 25: Severity of problems relating to administrative workload and time spent on 
coordination of care and shortages of GPs within practice areas.
Major problem Minor problem Not a problem
Amount of time you or your 
staff spends on administration 
(N=379; 99%)
245 (65%) 102 (27%) 28 (7%)
Amount of time you spend 
coordinating care for your 
patients (N=379; 99%)
212 (56%) 127 (33%) 36 (10%)
Shortage of GPs where you 
practice (N=379; 99%)
51 (13%) 122 (32%) 189 (50%)
Half of GPs believe that there is a shortage of GPs in the area in which they practice. The 
majority of GPs believe that the amount of time spent on administration and the amount of 
time spent coordinating care for their patients is a major problem. 
GPs who indicated that they were functioning as a part of a PCT were more likely to perceive 
there being no shortage of GPs in the area in which they practice and less likely to see the 
amount of time spent on administration and coordinating care for patients as a major problem. 
Table 26: Amount of time you or your staff, spend on administrative issues? 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Major problem Minor problem Not a problem
Ireland (N=380) 65 % 27 % 7 %
Australia (N=1016) 24 % 54 % 21 %
Canada (N=1401) 27 % 52 % 17 %
France (N=502) 49 % 36 % 12 %
Germany (N=715) 54 % 33 % 11 %
Italy (N=844) 85 % 12 % 2 %
Netherlands (N=614) 56 % 33 % 8 %
New Zealand (N=500) 29 % 56 % 16%
Norway (N=744) 13 % 55 % 30 %
Sweden (N=1450) 37 % 50 % 11 %
UK (N=1062) 19 % 49 % 27 %
US (N=1442) 57 % 27 % 9 %
Irish GPs perceive time spent on administrative tasks to be a major problem (65%), with Italy 
being the only country in the Commonwealth Fund study to report a higher figure (85%).
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Section Three: Results
Table 27: Amount of time you spend on coordinating care for your patients? 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Major problem Minor problem Not a problem
Ireland (N=380) 56% 33% 10%
Australia (N=1016) 17% 54% 29%
Canada (N=1401) 33% 49% 15%
France (N=502) 30% 36% 29%
Germany (N=715) 29% 45% 23%
Italy (N=844) 22% 52% 21%
Netherlands (N=614) 20% 54% 25%
New Zealand (N=500) 18% 51% 31%
Norway (N=744) 12% 63% 21%
Sweden (N=1450) 18% 60% 18%
UK (N=1062) 20% 48% 30%
US (N=1442) 30% 52% 14%
More than half of Irish GPs (56%) report that the time they spend on coordinating care for 
their patients is a major problem. This is a higher proportion than reported elsewhere among 
their international counterparts.
General practice in Ireland seems to be heavy on administration and management compared 
to international systems. It is difficult to explain this but it has to be remembered that two 
systems operate in Irish general practice – public and private – which are not administratively 
coherent. Clearly changes involving chronic disease care needs to address the issue of 
administration workload, as it is a costly part of the system.
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Table 28: Shortage of primary care doctors where you practice? Comparison 
between Ireland and data collected by Commonwealth Fund (2009) International 
Survey of Primary Care Doctors (1)
Major problem Minor problem Not a problem
Ireland (N=380) 13 % 32 % 50 %
Australia (N=1016) 30 % 51 % 19 %
Canada (N=1401) 69 % 23 % 6 %
France (N=502) 20 % 25 % 49 %
Germany (N=715) 12 % 23 % 52 %
Italy (N=844) 14 % 31 % 42 %
Netherlands (N=614) 5 % 15 % 60 %
New Zealand (N=500) 25 % 51 % 23 %
Norway (N=744) 9 % 35 % 53 %
Sweden (N=1450) 51 % 31 % 15 %
UK (N=1062) 9 % 29 % 57 %
US (N=1442) 26 % 34 % 37 %
There has been an improvement in the supply of GPs in Ireland with only 13% indicating it to 
be a big problem currently. The numbers applying to GP training schemes and the increase in 
training places would seem to ensure that there will be enough GPs in most parts of Ireland 
in the near to medium future. However, with a projected increase in workload through the 
management of chronic disease for example, the situation needs to be kept under review.
Information technology
This section illustrates the number of GPs who use electronic patient medical records within 
their practice and the types of systems utilised. It highlights the scale of usage of information 
technology systems for communication with patients through email, text messaging, etc. It 
describes the ease with which respondents can generate patient information and perform 
tasks using their current IT systems.
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Section Three: Results
Do you use electronic patient medical records in your practice? 
Figure 7: Numbers of GPs who use electronic patient records within their  
practice (N=378)
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A total of 310 (82%) respondents indicated that they use electronic patient medical records 
in their practices. Sixty eight (18%) respondents indicated that they do not use electronic 
patient medical records. GPs who had electronic patient medical records were more likely to 
have completed an audit cycle in the last 5 years. The gender of the GP had no bearing on 
whether they used electronic patient medical records. Younger GPs were more likely to use 
patient medical records than older GPs. GPs in larger practices with three or more doctors 
working within the practice were more likely than single-handed GPs to use electronic patient 
medical records. 
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Table 29: Do you use electronic patient medical records in your practice? Comparison 
between Ireland and data collected by Commonwealth Fund (2009) International 
Survey of Primary Care Doctors (1)
YES 
Ireland (N=380) 82%
Australia 95%
Canada 37%
France 68%
Germany 72%
Italy 94%
Netherlands 99%
New Zealand 97%
Norway 97%
Sweden 94%
UK 96%
US 46%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Irish GPs have invested in IT systems in their practices and this is reflected in the proportion 
of Irish GPs (82%) who use patient medical records, which compares well with their 
international counterparts.
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If yes, which [patient medical record] system? 
Figure 8: Medical records software systems in use (N=310)
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While there are many software systems in use the main electronic records systems are 
Socrates and Health One. 
Do you use any of the following technologies in your practice? 
Table 30: The use of technology within the practices. 
Yes, used 
routinely
Yes, used 
occasionally No
Electronic prescribing of medication (N=377; 99%) 311 (83%) 8 (2%) 58 (15%)
Electronic entry of clinical notes, including medical 
history and follow-up (N=378; 99%)
292 (77%) 13 (3%) 73 (20%)
Electronic access to your patients’ laboratory test 
results (N=378; 99%)
272 (72%) 11 (3%) 95 (25%)
Electronic alerts or prompts about ADRs or drug 
interaction (N=376; 98%)
240 (64%) 35 (9%) 101 (27%)
Electronic ordering of laboratory tests (N=373; 98%) 85 (23%) 6 (2%) 282 (75%)
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The majority of GPs do not electronically order laboratory tests. The majority of GPs do 
have routine electronic access to patients’ laboratory test results, have electronic alerts or 
prompts about drug interactions, electronic entry or clinical notes or electronic prescribing of 
medication. The gender of the GP had no bearing on the use of different types of technology 
for clinical management. Younger GPs and GPs who work in larger practices were more likely 
to use a variety of technologies within their practices, compared to older GPs and GPs who 
work in single-handed practices. 
Table 31: Do you use electronic prescribing of medication? Comparison between 
Ireland and data collected by Commonwealth Fund (2009) International Survey of 
Primary Care Doctors (1)
Yes, used routinely Yes, used occasionally No
Ireland (N=380) 83% 2% 15%
Australia (N=1016) 93% 2% 5%
Canada (N=1401) 27% 5% 65%
France (N=502) 57% 6% 37%
Germany (N=715) 60% 2% 33%
Italy (N=844) 90% 1% 8%
Netherlands (N=614) 98% 1% 1%
New Zealand (N=500) 94% * 5%
Norway (N=744) 41% 4% 54%
Sweden (N=1450) 93% 2% 5%
UK (N=1062) 89% 2% 8%
US (N=1442) 40% 7% 49%
Irish GPs report amongst the highest of their international counterparts for electronic 
prescribing of medication.
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Table 32: Do you have electronic entry of clinical notes, including medical 
history and follow-up notes? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Yes, used routinely Yes, used occasionally No
Ireland (N=380) 77% 3% 20%
Australia (N=1016) 92% 4% 5%
Canada (N=1401) 30% 5% 64%
France (N=502) 60% 9% 31%
Germany (N=715) 59% 10% 30%
Italy (N=844) 82% 6% 11%
Netherlands (N=614) 96% 2% 2%
New Zealand (N=500) 96% 1% 3%
Norway (N=744) 81% 7% 11%
Sweden (N=1450) 89% 4% 7%
UK (N=1062) 97% 2% 1%
US (N=1442) 42% 5% 51%
Irish GPs’ reported use of electronic entry of clinical notes (77%) is comparable to GPs 
represented in the International Survey of Primary Care Doctors.
Table 33: Do you have electronic access to your patients’ laboratory test results? 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Yes, used routinely Yes, used occasionally No
Ireland (N=380) 72% 3% 25%
Australia (N=1016) 93% 4% 4%
Canada (N=1401) 41% 16% 42%
France (N=502) 36% 10% 54%
Germany (N=715) 80% 2% 18%
Italy (N=844) 50% 14% 34%
Netherlands (N=614) 76% 8% 15%
New Zealand (N=500) 92% 1% 7%
Norway (N=744) 94% 2% 4%
Sweden (N=1450) 91% 1% 7%
UK (N=1062) 89% 6% 5%
US (N=1442) 59% 15% 23%
Irish GPs (72%) report a comparable level of electronic access to patients’ laboratory results, 
as their international counterparts.
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Table 34: Do you get electronic alerts or prompts about a potential problem with 
drug dose or drug interaction? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Yes, used routinely Yes, used occasionally No
Ireland (N=380) 64% 9% 27%
Australia (N=1016) 92% 3% 4%
Canada (N=1401) 20% 11% 68%
France (N=502) 43% 14% 43%
Germany (N=715) 24% 18% 56%
Italy (N=844) 74% 10% 15%
Netherlands (N=614) 95% 2% 2%
New Zealand (N=500) 90% 2% 7%
Norway (N=744) 10% 19% 71%
Sweden (N=1450) 58% 18% 23%
UK (N=1062) 93% 4% 3%
US (N=1442) 37% 11% 49%
Irish GPs report availability of electronic alerts to potential drug interactions to an extent 
which is comparable to that reported by GPs in the Commonwealth Fund study.
Table 35: Do you use electronic ordering of laboratory test results? Comparison 
between Ireland and data collected by Commonwealth Fund (2009) International 
Survey of Primary Care Doctors (1)
Yes, used routinely Yes, used occasionally No
Ireland (N=380) 23% 2% 75%
Australia (N=1016) 86% 4% 11%
Canada (N=1401) 18% 5% 76%
France (N=502) 40% 10% 49%
Germany (N=715) 62% 3% 34%
Italy (N=844) 91% 1% 8%
Netherlands (N=614) 6% 6% 87%
New Zealand (N=500) 64% 1% 35%
Norway (N=744) 45% 5% 50%
Sweden (N=1450) 81% 2% 16%
UK (N=1062) 35% 5% 60%
US (N=1442) 38% 8% 52%
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Use of electronic ordering of laboratory test results is less frequently reported by Irish GPs 
relative to their international counterparts.
It is evident from data in these tables that Irish GPs utilise electronic record systems to 
a significant extent, and certainly are comparable with their international colleagues in 
most areas. It is also evident that there is scope to further improve the extent to which the 
efficiencies possible using electronic handling of information in the routine care of patients 
and patient subgroups can be further improved.
How often does your practice communicate with patients by email? 
Figure 9: Numbers of practices that communicate with patients by email (N=378)
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Seven respondents (2%) indicated that their practices often communicate with patients by 
email. 37 (10%) indicated that their practices sometimes communicate with patients by email. 
119 (31%) indicated that their practices rarely communicate with patients by email. 215 (57%) 
indicated that their practices never communicate with patients by email. The gender of the GP 
had no bearing on whether they communicated with patients by email. Younger GPs and GPs 
who worked in larger practices were more likely to communicate with patients by email than 
older GPs and GPs who work in single-handed practices. 
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Table 36: How often does your practice communicate with patients by email for 
clinical or administrative purposes? Comparison between Ireland and data collected 
by Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Often Sometimes Rarely Never
Ireland (N=380) 2% 10% 31% 57%
Australia 1% 16% 52% 30%
Canada 1% 5% 17% 75%
France 2% 7% 22% 68%
Germany 2% 12% 28% 57%
Italy - - - -
Netherlands 7% 24% 40% 29%
New Zealand 1% 16% 63% 20%
Norway 3% 11% 29% 56%
Sweden 9% 26% 41% 24%
UK 6% 13% 33% 48%
US 4% 10% 26% 58%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Use of email for clinical or administrative purposes by Irish GPs is similar to that of their 
international counterparts.
How often does your practice communicate with patients by SMS Text? 
Figure 10: Number of practices that communicate with patients by SMS text (N=378)
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Section Three: Results
The majority of GPs responding (78%) indicate that they rarely or never communicate with 
patients by SMS text.
Twenty-nine (8%) respondents indicated that their practices often communicate with patients 
by SMS Text. 54 (14%) indicated that their practices sometimes communicate with patients by 
SMS Text. 77 (20%) indicated that their practices rarely communicate with patients by SMS 
Text. 218 (58%) indicated that their practices never communicate with patients by SMS Text. 
Neither the gender nor the age of the GP had any bearing on whether they communicated with 
patients via text. GPs in larger practices were more likely to communicate with patients via 
text then GPs working in smaller sized practices. 
There is a high level of IT use in Irish general practice that reflects years of investment and 
training on the parts of the State and GPs themselves. The problem of poor synchronisation 
with hospitals has improved in the laboratory area but remains poor with other parts 
of secondary care. The plan for electronic referral letters will be a major improvement if 
implemented.
With the patient medical records system you currently have, how easy would 
it be to generate the following information about your patients? 
Table 37: The ease with which respondents can generate patient information using 
their current medical records system. 
Easy Difficult Cannot 
generate
Is this process 
computerised?
Yes
List of all individual patients’ 
medications (N=378; 99%)
336 (89%) 22 (6%) 20 (5%) 274 (82%) N=333
Patients due or overdue for 
a service (e.g. Flu Vaccine) 
(N=373; 97%)
187 (50%) 131 (35%) 55 (15%) 245 (76%) N=321
List of patients by lab result 
(e.g. HbA1C) (N=367; 96%)
176 (48%) 129 (35%) 62 (17%) 231 (72%) N=320
List of patients by diagnosis 
(e.g. HTN) (N=375; 98%)
178 (47%) 152 (41%) 45 (12%) 255 (78%) N=329
The majority of GPs responding report generation of a list of medications for an individual 
patient to be easy and half of GPs can generate a list of patients who are due or overdue for 
a vaccination. In each case where the GP indicated that they found each process ‘easy’ they 
were more likely to have this process computer generated. The majority of GPs either find 
it difficult or cannot generate a list of patients by diagnosis or by lab result. The gender of 
the GP had no bearing on the ease with which they reported being able to generate patient 
information. Younger GPs and GPs in larger sized practices were more likely than older GPs 
and GPs working in smaller practices to report being able to generate patient information 
using their current medical records systems. 
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Table 38: With the patient records system that you currently have, how easy would 
it be for you to generate a list of all medications taken by an individual patient? 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Easy Difficult Cannot  
generate
Is this process 
computerised?
Yes
Ireland (N=378) 89% 6% 5% 82%
Australia 71% 27% 2% 94%
Canada 33% 29% 33% 25%
France 43% 28% 27% 24%
Germany 55% 22% 17% 65%
Italy 53% 37% 9% 78%
Netherlands 70% 23% 7% 61%
New Zealand 57% 41% 2% 96%
Norway 57% 23% 14% 45%
Sweden 43% 20% 33% 49%
UK 89% 7% 2% 86%
US 45% 29% 20% 30%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Irish GPs report generation of medication lists for individual patients to be easy, a similar 
level to that reported in the UK and higher than that reported by the rest of their  
international counterparts.
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Table 39: With the patient records system that you currently have, how easy would 
it be for you to generate a list of patients who are due or overdue for tests or 
preventive care? Comparison between Ireland and data collected by Commonwealth 
Fund (2009) International Survey of Primary Care Doctors (1)
Easy Difficult Cannot  
generate
Is this process 
computerised?
Yes
Ireland (N=373) 50% 35% 15% 76%
Australia 63% 34% 2% 95%
Canada 18% 33% 43% 22%
France 32% 35% 28% 19%
Germany 37% 38% 20% 65%
Italy 46% 46% 7% 76%
Netherlands 65% 35% * 69%
New Zealand 57% 41% 2% 96%
Norway 7% 50% 37% 32%
Sweden 21% 31% 42% 41%
UK 90% 9% 1% 89%
US 24% 40% 31% 29%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Irish GPs’ ease in generating recalls for tests/preventive care, compares well with GPs 
reporting in the Commonwealth Fund International Survey of Primary Care Doctors.
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Table 40: With the patient records system that you currently have, how easy would 
it be for you to generate a list of patients by lab result? Comparison between Ireland 
and data collected by Commonwealth Fund (2009) International Survey of Primary 
Care Doctors (1)
Easy Difficult Cannot 
 generate
Is this process 
computerised?
Yes
Ireland (N=367) 48% 35% 17% 72%
Australia 52% 39% 8% 88%
Canada 19% 28% 47% 23%
France 19% 34% 37% 15%
Germany 20% 40% 33% 56%
Italy 43% 49% 8% 76%
Netherlands 37% 53% 7% 62%
New Zealand 44% 41% 15% 84%
Norway 30% 46% 16% 49%
Sweden 46% 31% 18% 67%
UK 77% 15% 2% 85%
US 25% 36% 33% 29%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Irish GPs ease in listing patients by lab result is comparable with their international 
counterparts.
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Table 41: With the patient records system that you currently have, how easy would it 
be for you to generate a list of patients by diagnosis? Comparison between Ireland 
and data collected by Commonwealth Fund (2009) International Survey of Primary 
Care Doctors (1)
Easy Difficult Cannot generate Is this process computerised?
Yes
Ireland (N=375) 47% 41% 12% 78%
Australia 61% 36% 3% 93%
Canada 34% 33% 28% 37%
France 30% 34% 27% 20%
Germany 68% 19% 8% 82%
Italy 74% 22% 3% 86%
Netherlands 67% 32% * 73%
New Zealand 56% 42% 2% 97%
Norway 51% 34% 9% 57%
Sweden 56% 29% 12% 74%
UK 97% * * 90%
US 41% 35% 19% 42%
Footnote: Australia (N=1016); Canada (N=1401); France (N=502); Germany (N=715); Italy (N=844); 
Netherlands (N=614); New Zealand (N=500); Norway (N=744); Sweden N=1450); UK (N=1062); US 
(N=1442)
Almost half of Irish GPs (47%) reported ease in generating a list of patients by diagnosis.  
This figure is in the lower third by comparison with international counterparts.
Are the following tasks routinely performed in your office practice? 
Table 42: Tasks that are routinely performed within the practice. 
Yes, using a 
computerised system
Yes, using a 
manual system No
All laboratory tests are 
tracked until results reach 
clinicians (N=376; 98%)
147 (39%) 94 (25%) 135 (36%)
Patients are sent reminder 
notices (e.g., flu vaccine or BP 
check) (N=377; 98%)
92 (24%) 79 (21%) 206 (55%)
You receive an alert or prompt 
to provide patients with test 
results (N=375; 97%)
73 (19%) 60 (16%) 242 (65%)
You receive a reminder for 
guideline-based interventions 
(N=373; 97%)
22 (6%) 17 (5%) 334 (89%)
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In the majority of cases, tasks such as patients being sent a reminder notice, or the GP 
receiving an alert to provide patients with test results or a reminder to utilise guideline based 
interventions are not routinely performed in the practices. However, in the majority of cases 
laboratory tests are tracked until results reach clinicians. Where these tasks are routinely 
performed it is typically using a computer rather than a manual system. 
GPs in larger practices, younger GPs and GPs who had previously reported having electronic 
patient medical records in their practices were most likely to send their patients reminder 
notices. GPs in larger practices and who had previously indicated that they use electronic 
patient medical records were most likely to have laboratory tests tracked until results reach 
clinicians and were also more likely to receive an alert to provide patients with test results. 
GPs who had previously indicated that they have electronic patient medical records were 
more likely to receive a reminder for guideline based interventions. The gender of the GP 
made no difference to any of the above tasks being performed. 
Table 43: All laboratory tests ordered are tracked until results reach clinicians. 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Yes, using a 
computerised system
Yes, using a 
manual system No
Ireland (N=376) 39% 25% 36%
Australia (N=1016) 69% 10% 21%
Canada (N=1401) 13% 25% 59%
France (N=502) 25% 37% 36%
Germany (N=715) 40% 33% 23%
Italy (N=844) 59% 8% 33%
Netherlands (N=614) 28% 8% 62%
New Zealand (N=500) 56% 5% 39%
Norway (N=744) 28% 9% 58%
Sweden (N=1450) 50% 7% 38%
UK (N=1062) 60% 10% 27%
US (N=1442) 28% 40% 28%
Irish GPs’ use of laboratory test tracking is concordant with that of GPs reported in the 
Commonwealth Fund survey.
56
Section Three: Results
Table 44: Patients are sent reminder notices when it is time for regular preventive or 
follow-up care (e.g. flu vaccine)? Comparison between Ireland and data collected by 
Commonwealth Fund (2009) International Survey of Primary Care Doctors (1)
Yes, using a 
computerised system
Yes, using a 
manual system No
Ireland (N=377) 24% 21% 55%
Australia (N=1016) 82% 7% 11%
Canada (N=1401) 10% 21% 66%
France (N=502) 24% 35% 40%
Germany (N=715) 17% 15% 64%
Italy (N=844) 9% 24% 66%
Netherlands (N=614) 48% 31% 20%
New Zealand (N=500) 92% 4% 3%
Norway (N=744) 3% 12% 84%
Sweden (N=1450) 26% 25% 47%
UK (N=1062) 76% 21% 2%
US (N=1442) 18% 29% 49%
Irish GPs’ reported use of reminder notices is comparable with most of their international 
counterparts. 
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Table 45: You receive an alert or prompt to provide patients with test results. 
Comparison between Ireland and data collected by Commonwealth Fund (2009) 
International Survey of Primary Care Doctors (1)
Yes, using a 
computerised system
Yes, using a 
manual system No
Ireland (N=380) 19% 16% 65%
Australia (N=1016) 68% 7% 24%
Canada (N=1401) 12% 27% 59%
France (N=502) 11% 26% 63%
Germany (N=715) 11% 21% 66%
Italy (N=844) 19% 14% 67%
Netherlands (N=614) 8% 9% 83%
New Zealand (N=500) 41% 5% 54%
Norway (N=744) 26% 12% 62%
Sweden (N=1450) 15% 11% 72%
UK (N=1062) 49% 11% 39%
US (N=1442) 22% 28% 47%
Irish GPs receive alerts/prompts to provide patients with test results to a similar extent to 
their international counterparts.
Table 46: You receive a reminder for guideline-based intervention and/or screening 
results. Comparison between Ireland and data collected by Commonwealth Fund 
(2009) International Survey of Primary Care Doctors (1)
Yes, using a 
computerised system
Yes, using a 
manual system No
Ireland (N=380) 6% 5% 89%
Australia (N=1016) 67% 6% 27%
Canada (N=1401) 9% 17% 71%
France (N=502) 27% 27% 45%
Germany (N=715) 12% 10% 77%
Italy (N=844) 31% 16% 52%
Netherlands (N=614) 9% 7% 83%
New Zealand (N=500) 45% 4% 51%
Norway (N=744) 7% 9% 83%
Sweden (N=1450) 4% 6% 88%
UK (N=1062) 62% 10% 26%
US (N=1442) 20% 19% 58%
58
Section Three: Results
Availability of reminders for guideline-based intervention is relatively low compared to the 
majority of the other countries in the Commonwealth Fund survey.
Data from these tables indicate substantial use of information technology in the execution 
of tasks regarded as integral to good chronic disease management throughout the countries 
studied, and with activities in Irish practice broadly comparable. More particularly, Irish 
practice appears to compare favourably in the area of prescribing, average in the area of 
triggering preventive actions and management of laboratory data, and less good in the use of 
IT systems to provide guideline based prompts and reminders. 
These data will be relevant for the ongoing process of professionally led standard setting in the 
area of determining specifications for clinical record system software development in the future.
Barriers to effective chronic disease management
This section outlines the importance of perceived barriers to the effective delivery of chronic 
disease management in the community. 
Please rate the following in terms of your perceived importance as being 
barriers to the effective management of chronic diseases in your practice:
Table 47: Perceived importance of barriers to effective management of chronic 
diseases within the practice. 
Extremely 
important Not important Important
Increased workload/lack of time  
(N=379; 99%)
310 (82%) 18 (5%) 51 (13%)
Lack of appropriate funding (N=378; 98%) 286 (76%) 33 (9%) 59 (15%)
Poor communication between hospital 
teams and general practitioners  
(N=379; 99%)
206 (55%) 66 (17%) 107 (28%)
Lack of ongoing access to specialists for 
advice (N=379; 99%)
217 (37%) 55 (15%) 107 (28%)
Lack of skills and education/knowledge 
gaps (N=377; 97%)
91 (24%) 154 (41%) 132 (35%)
The respondents report increased workload/lack of time as being extremely important more 
frequently than any other perceived difficulty in effective chronic disease management.
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The majority of GPs considered the lack of appropriate funding, poor communication between 
hospital teams and GPs, an increase in workload and a lack of ongoing access to specialists 
for advice as extremely important barriers to the effective management of chronic diseases. 
The majority considered a lack of skills and education was an important barrier. Neither 
the age nor gender of the responding GP had any influence on the perception of barriers to 
CDM. However GPs working in larger practices with three or more doctors were more likely to 
perceive a lack of appropriate funding, poor communication between hospital teams and GPs 
and an increase in work load as an important barrier to effective CDM. 
Future development of chronic disease management
This section examines GPs’ perceptions of the importance of resources for the development 
of CDM and their opinion on shared care initiatives between GPs and hospitals. 
Please rate the following resources in terms of importance that would allow 
you to further develop CDM in your practice
Table 48: Rating of resources in terms of importance in the development of chronic 
disease management within the practice. 
Extremely 
important Not important Important
Specific payments for patients with a 
major chronic disease (N=374; 95%)
292 (78%) 33 (9%) 49 (13%)
Targeted funding as in the NHS model 
(N=365; 96%)
244 (68%) 46 (12%) 75 (20%)
Increased practice nurse time for clinics 
(N=372; 96%)
232 (62%) 38 (10%) 102 (28%)
GP led CDM clinics (N=370; 96%) 199 (54%) 61 (16%) 110 (30%)
Specialist nurse led clinics (N=374; 97%) 184 (49%) 82 (21%) 108 (30%)
Respondents identify specific payments for patients with a major chronic disease as being 
extremely important.
The majority of GPs believe that GP led CDM clinics, increases in practice nurse time for 
clinics, targeted funding as in the NHS model, specialist nurse led clinics and specific 
payments for patients with a major chronic disease are extremely important resources to 
develop CDM. 
Younger GPs were more inclined to believe that increased practice nurse time, targeted 
funding and specific payments were important compared to older GPs. GPs working in larger 
practices were more likely to perceive targeted funding and specific payments for patients 
with a major chronic disease as important. The gender of the GP had no bearing on ratings in 
terms of development of CDM. 
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Based on these responses, GPs would be positively disposed to addressing the issues 
of time pressure and poor communications with secondary care, together with targeted 
payments similar to the Quality Outcomes Framework in the NHS, based on individual patient 
diagnoses.
With regard to shared care of chronic disease between general practice and 
the hospital:
Table 49: GPs’ opinion of shared care between general practice and hospitals. 
Yes
Do you think there is a place for shared care in CDM between 
General Practice and the hospital? (N=378; 98%) 
373 (99%)
Would you support a shared care initiative in CDM between 
your practice and your local hospital? (N=376; 97%) 
367 (98%)
Do you think a shared care initiative between GP and 
hospital, could be run by nurses? (N=372; 96%)
258 (69%)
Are you currently involved in any shared care of a chronic 
disease? (N=376; 97%)
168 (45%)
GPs responded positively on the prospective use of shared care in CDM between general 
practice and hospital.
The majority of GPs welcomed the concept of shared care in CDM between GP and hospitals. 
Over two thirds of GPs welcomed a shared care initiative between themselves and a hospital 
that could be run by a nurse. Nearly half of the GPs indicated that they are currently involved 
in shared care of a chronic disease. Being currently involved in shared care did not influence 
GPs’ perceptions on shared care compared with GPs who are not involved in shared care. 
Of those 168 GPs who indicated that they are involved in shared care, a total of 125 (74%) 
respondents said the shared care that they are involved in is working. Neither the age nor 
gender of the GP, nor the size of the practice in which they worked had any bearing on the 
opinion of shared care initiatives between general practice and hospitals. 
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Section Four: Discussion
This is the first national survey of chronic disease management in Irish General Practice, which 
can be used as a baseline to measure future change. It is a ‘stock taking’ exercise to ascertain 
the current practice and level of interest there is amongst GP Colleagues to manage chronic 
disease in their practice communities. The questions were drawn from the “eleven countries 
Commonwealth study” (1) with added local questions. This allows us to make international 
comparisons of our results with other healthcare systems. The response rate of 72% achieved 
in the study shows that GPs are interested in the concept of chronic disease management within 
their practice population. 
The majority think that that there are some good things in the Irish healthcare system but 
significant changes are needed to make CDM work better. In comparison to the 11 country data, 
Irish GPs are least likely to rate the healthcare system as working well. This is not surprising as 
primary care has been led to the top of the hill with the primary care strategy and has had to find 
its own way after that. Changes proposed by our new Government will hopefully provide policy 
direction that is badly needed for primary care.
Substantial differences remain in access between fee paying patients and GMS eligible patients 
in terms of access to diagnostics and also to associated disciplines. International comparisons 
indicate the degree of such access for Irish private patients is comparable internationally; access 
for GMS patients as an important subgroup is significantly less good. The fact that patients with 
CDM are more likely to be over represented in the GMS subgroup and have poorer access to 
diagnostics and specialist care is a cause for particular concern.
GPs reported widespread use of IT and electronic patient medical records. When compared with 
the 11 country study Ireland has the same rate of use of IT systems within the practices. Thus 
there is significant infrastructure in place for the task of providing accountable high quality 
care for chronic disease in Irish general practice, and data from this study provides direction in 
terms of which aspects of IT application and development should be preferentially augmented 
and singled out for further development. Integrated guideline based prompts and automated 
reminders need particular attention. 
Inequality appears to be ingrained in Irish general practice, with GPs believing that their GMS 
entitled patients often have greater difficultly than the fee-paying patients getting specialised 
diagnostic tests; often experience longer waiting times to see a hospital based specialist, 
and often experience longer waiting times to receive treatment after diagnosis. On the other 
hand, fee-paying patients sometimes have more difficulty than GMS entitled patients paying 
for medications or other out-of-pocket costs. It is surprising that similar inequalities operate in 
other better-funded and better-organised systems than ours. It is the scale of inequality that is 
different in Ireland, which is a poor reflection of our past decade of unprecedented wealth.
A total of 375 (99%) respondents indicated that they have an out-of-hours service for their 
patients with the majority working within a Co-Op system. This rates better than the 11 Countries 
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systems. In fact when Ireland is compared against the 11 study data we offer the best coverage of 
out-of-hours within the group. 
There is a small amount of clinical audit being routinely performed on any chronic diseases. 
This may change as a result of the Medical Council’s requirements for GPs to conduct audits 
within their practice as part of competence assurance. It is a capacity issue and GPs will need 
considerable support if we are to provide accountable, good quality care in chronic disease 
management.
Compared to 11 country data Irish GPs are using evidence-based guidelines with the same 
frequency as their international counterparts for diabetes, asthma or COPD and hypertension. 
There is less use of guidelines for depression and ADHD when compared internationally, that may 
be a reaction to the low level of trusted guidance being provided. There is an undue emphasis 
on pharmaceutical guidance in these areas which GPs may not trust and we recommend more 
dialogue between psychiatrists, including child psychiatrists, and GPs in this area.
Irish GPs consider a shortage of other GPs practicing in their areas as a minor problem, but 
are more likely to consider time spent on administration as a major problem compared to their 
international counterparts; and are also more likely to consider time spent co-ordinating care for 
patients as a major problem compared to their international counterparts. Irish general practice 
has to accommodate both private and public systems at both primary and secondary care levels, 
which adds complexity and challenges and an increased administration workload. Irish GPs are 
also interested in targeted payments for the management of chronic disease, which is a way 
forward for the profession and the Government. 
Approximately one third of respondents indicated that they believe they are part of a functioning 
primary care team. Ten years on from the Government’s Primary Care Strategy document (2) it 
would appear that advances could still be made to roll out fully functioning primary care teams 
within Irish communities. Irish GPs believe that there is good support for shared care initiatives 
between themselves and local hospitals. The evidence for shared care is weak and much effort 
can be expended in this area because it seems like a good idea. We think the effort is better 
placed within practices, by placing emphasis on clinical organisation, assuring quality of care and 
up-skilling all members of the practice. 
Care integration is most sensibly located where the whole person is cared for – in general 
practice. Arguably, general practice’s role has been, and should be, further strengthened, as 
the medical hub for chronic disease management with spokes of speciality care feeding in. 
Much greater availability and integration with PCTs would strengthen chronic care in the Irish 
community. The IT infrastructure which is reported to be further developed than countries such 
as the US and Canada, is a good base from which to improve the provision of formal disease 
registers, reminder systems, and potential medication problem alerts and to support better 
communications within the practice teams and the wider care systems.
The Chronic Care Model provides a very useful framework for a baseline snapshot of GP 
perceptions of chronic care in Ireland. The snapshot, and comparisons with international 
colleagues indicate that Irish chronic disease management has considerable strengths, but 
room for improvements. Eliciting patients’ perspectives on chronic disease management is an 
important next step. Over time repeating this snapshot and including patient perceptions will 
provide an evaluation of progress towards improving chronic care in Ireland. 
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Appendix: Survey Instrument
 
Department of Public Health & Primary Care, Trinity College Dublin
National Survey of Chronic Disease Management in General Practice
1.  Which of the following statements come closest to expressing your overall view of chronic 
disease management (CDM) in our health care system?
□  On the whole, the health care system works pretty well, and only minor changes are necessary to 
make CDM work better.
□  There are some good things in our health system, but significant changes are needed to make 
CDM work better.
□  Our health care system has so much wrong with it that we need to completely rebuild it for CDM.
2a.  How often do your fee paying patients experience the following? 
Often Sometimes Rarely Never
a.  Have difficulty paying for medications or other 
out-of-pocket costs
□ □ □ □
b.  Have difficulty getting specialised diagnostic 
tests (e.g., CT imaging)
□ □ □ □
c.  Experience long waiting times to see a hospital 
based specialist 
□ □ □ □
d.  Experience long waiting times to receive 
treatment after diagnosis
□ □ □ □
2b. How often do your GMS entitled patients experience the following? 
Often Sometimes Rarely Never
a.  Have difficulty paying for medications or other 
out-of-pocket costs
□ □ □ □
b.  Have difficulty getting specialised diagnostic 
tests (e.g., CT imaging)
□ □ □ □
c.  Experience long waiting times to see a hospital 
based specialist 
□ □ □ □
d.  Experience long waiting times to receive 
treatment after diagnosis
□ □ □ □
3.  What out of hours service does your practice utilise (tick all that apply) ? 
Local rota □  Co-op □  Deputising service □  No Service (Excluding A&E) □
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4.   Does your practice routinely use written evidence-based treatment guidelines to treat the 
following conditions?
(e.g., ICGP, NICE, or SIGN Guidelines)
Yes, Routinely use 
Guidelines
No, Do Not Routinely 
Use Guidelines
No Guidelines 
Available
a. Diabetes □ □ □
b. Depression □ □ □
c. Asthma or COPD □ □ □
d. Hypertension □ □ □
e. ADHD □ □ □
5.  Do you provide patients, who take multiple medications (e.g. 5 or more) with a written list 
of their medications ?
□ Yes, routinely  □ Yes, occasionally  □ No
6.  Do you give your patients with chronic diseases written instructions about how to manage 
their own care at home? 
□ Yes, routinely  □ Yes, occasionally  □ No
7. Have you completed a full Audit Cycle within the last 5 yrs on 1 or more chronic diseases? 
□ Yes  □ No
8.  In your own practice, other than doctors, does your practice include any other health care 
providers?
Practice nurse □ Psychologist □ Practice Manager □
Receptionist □ Dietitian □ Counsellor □
Administrator □ Chiropodist □ Other □
9.  Please rate the strength of your agreement with the following statements:
1= Strongly disagree  2 =Disagree  3=Neither agree/disagree  4=Agree  5=Strongly agree
I am happy with CDM as it is 1 2 3 4 5
I want to put more time and energy into CDM here in the practice 1 2 3 4 5
Primary care teams will enhance the way chronic disease  
is managed in my practice
1 2 3 4 5
My local hospital should put more time and energy into CDM 1 2 3 4 5
I am willing to share the CDM workload with my local hospital 1 2 3 4 5
CDM should take place largely at a practice level and delivered  
largely by GPs
1 2 3 4 5
CDM should take place largely at a practice level by nurses,  
under GP supervision
1 2 3 4 5
CDM should take place largely at a practice level by nurses 
working independently of GPs
1 2 3 4 5
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10. Is your practice functioning as part of a primary care team?
□ Yes  □ No
11.  Outside of your practice, do your patients have effective local access to the following?
 Private patients GMS patients
Physiotherapist □  □
Occupational therapist □  □
Speech and language therapist □  □
Chiropodist □ □
Psychologist □ □
Dietician □ □
Social worker □ □
12a.  When your patients have been seen by a hospital specialist, privately, how often do the 
following occur?
Always Often Sometimes Rarely Never
You receive a report from the specialist 
with all relevant information 
□ □ □ □ □
The information you receive is timely; 
that is available when needed 
□ □ □ □ □
12b.  When your patients have been seen by a hospital specialist, publicly, how often do the 
following occur?
Always Often Sometimes Rarely Never
You receive a report from the specialist 
with all relevant information 
□ □ □ □ □
The information you receive is timely; 
that is available when needed 
□ □ □ □ □
13a. Do you use electronic patient medical records in your practice?
□ Yes  □ No
13b.  If yes, which system?
14.  Do you use any of the following technologies in your practice?
Yes, used 
routinely
Yes, used 
occasionally
No
a.  Electronic ordering of laboratory tests □ □ □
b.  Electronic access to your patients’ 
laboratory test results
□ □ □
c.  Electronic alerts or prompts about ADRs or 
drug interaction
□ □ □
d.  Electronic entry of clinical notes, including 
medical history and follow-up 
□ □ □
e.  Electronic prescribing of medication □ □ □
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15.  How often does your practice communicate with patients by email?
□ Often    □ Sometimes    □ Rarely    □ Never
16. How often does your practice communicate with patients by SMS Text ?
□ Often    □ Sometimes    □ Rarely    □ Never
17.  With the patient medical records system you currently have, how easy would it be to 
generate the following information about your patients? 
Ease/Difficulty Is Process Computerised?
Easy Somewhat 
Difficult
Difficult Cannot 
Generate
Yes No
a.  List of patients by 
diagnosis (e.g. HTN)
□ □ □ □ □ □
b.  List of patients by lab 
result (e.g., HbA1C)
□ □ □ □ □ □
c.  Patients due or overdue 
for (e.g. Flu Vaccine)
□ □ □ □ □ □
d.  List of all medications of 
a patient
□ □ □ □ □ □
18. Are the following tasks routinely performed in your office practice?
Yes, using a 
computerised System
Yes, using a manual 
System
No
a.  Patients are sent reminder notices 
(e.g., flu vaccine or BP)
□ □ □
b.  All laboratory tests ordered are 
tracked until results reach clinicians
□ □ □
c.  You receive an alert or prompt to 
provide patients with test results
□ □ □
d.  You receive a reminder for guideline-
based interventions 
□ □ □
19.  How much of a problem, if any, are the following?
Major 
Problem
Minor 
Problem
Not a 
Problem
Not 
Applicable
a.  Shortage of GPs where you practice □ □ □ □
b.  Amount of time you or your staff spends  
on administration
□ □ □ □
c.  Amount of time you spend coordinating  
care for your patients
□ □ □ □
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20.  How often do you currently use the following approaches to improving care for patients 
with diabetes?
1=Never,   2=Rarely,   3=Occasionally,   4=Usually,   5=Always
Use a register to identify and/or track care of your patients 1 2 3 4 5
Use a tracking system to remind patients about needed visits 1 2 3 4 5
Follow up patients between visits by telephone (you or staff) 1 2 3 4 5
Use published practice guidelines as the basis for your management 1 2 3 4 5
Involve office staff in reminding patients in need of follow-up or other services 1 2 3 4 5
Assist patients in setting and attaining self-management goals 1 2 3 4 5
Refer patients to someone within your practice for education about  
their diabetes
1 2 3 4 5
Refer patients to someone outside your practice for education about their diabetes 1 2 3 4 5
Use flow sheets to track critical elements of care 1 2 3 4 5
21.  Please rate the following in terms of your perceived importance as being barriers to the 
effective management of chronic diseases in your practice:
1=Not important,  2=A little important,  3=Important,  4=Very important,  5=Extremely important
a. Lack of appropriate funding 1 2 3 4 5
b. Lack of skills and education / knowledge gaps 1 2 3 4 5
c. Poor communication between hospital teams and general practitioners 1 2 3 4 5
d. Increased workload / lack of time 1 2 3 4 5
e. Lack of ongoing access to specialists for advice 1 2 3 4 5
22.  Please rate the following resources in terms of importance that would allow you to further 
develop CDM in your practice?
1=Not important,  2=A little important,  3=Important,  4=Very important,  5=Extremely important
a. GP led CDM clinics 1 2 3 4 5
b. Specialist nurse led clinics 1 2 3 4 5
c. Increased practice nurse time for clinics 1 2 3 4 5
d. Targeted funding as in the NHS model 1 2 3 4 5
e. Specific payments for patients with a major chronic disease 1 2 3 4 5
(E.g. COPD, CVD, Diabetes)
23.  With regard to Shared Care of chronic disease between general practice and the hospital:
a.  Do you think there is a place for shared care in CDM between 
General Practice and the hospital?
□ Yes □ No
b.  Would you support a shared care initiative in CDM between your 
practice & your local hospital?
□ Yes □ No
c.  Do you think a shared care initiative between GP & hospital could 
be run by nurses? 
□ Yes □ No
d. Are you currently involved in any shared care of a chronic disease? □ Yes □ No
24.  If you are currently involved in shared care, is it working?
□ Yes  □ No  □ Not applicable
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PRACTICE PROFILE & DEMOGRAPHIC DATA
25. Where is your practice located? 
□ City □  Suburban □ Small town □ Rural
26. Your Age Category:
□ Under 35 □ 35-49 □ 50-64 □ 65 or older
27. Your Sex:
□ Male □ Female
28. Which of the following describes you practice?
□ A single handed practice  □ A two doctor practice  □ A three or more doctor practice
29.  Is your practice part of an integrated provider system (e.g. Centric, Touchstone etc.)? □ 
□ Yes  □ No
30. About what percentage of your patients are in each of the following categories? 
Total can add to more than 100%.
      % Full Medical Card       % Doctor Only card
      % Private fee paying       % Other (please specify)
31. Is your practice involved in Training?  
□ Yes  □ No
If yes, are you involved in   □ Undergraduate   □ Post-graduate
THANK YOU FOR YOUR TIME & CO-OPERATION
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